Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

3 Biotech Stocks That Could Double in 2022

TheMotleyFool

0 0

3 Biotech Stocks That Could Double in 2022

Could you get a twofold return in 2022? Some stocks just might give you a good chance at achieving that goal.

We asked three Motley Fool contributors which biotech stocks they think could double in the new year. Here's why they picked Adicet Bio (NASDAQ: ACET), ChemoCentryx (NASDAQ: CCXI), and NRx Pharmaceuticals (NASDAQ: NRXP).

Image source: Getty Images.

Source Fool.com

Like: 0

ACET

Share